Key result
Myocardial work efficiency and biomarker nomogram predicts severe stenosis in stable CAD with AUC ~0.91.
Why the study?
Non-invasive identification of coronary stenosis in stable CAD patients lacking resting regional wall motion abnormalities remains challenging.
Does a nomogram incorporating global myocardial work efficiency and clinical biomarkers accurately predict severe coronary stenosis in stable CAD patients with preserved LVEF and no regional wall motion abnormalities?
Does a nomogram incorporating global myocardial work efficiency and clinical biomarkers accurately predict severe coronary stenosis in stable CAD patients with preserved LVEF and no regional wall motion abnormalities?
A novel nomogram combining echocardiographic global myocardial work efficiency and clinical biomarkers accurately predicts severe coronary stenosis in stable CAD patients with preserved LVEF, potentially optimizing the use of invasive diagnostics.
Answers are grounded in this paper and cite their sources.
May aid noninvasive stratification in stable CAD without RWMA; hypothesis-generating and requires prospective validation before practice change.
Background: Non-invasive identification of coronary stenosis in stable coronary artery disease (CAD) patients lacking regional wall motion abnormalities (RWMA) remains challenging. This study aimed to develop and validate a myocardial work-derived nomogram for predicting significant coronary stenosis in these patients. Methods: In this retrospective study, 181 consecutive patients with angiographically confirmed CAD, preserved LVEF (≥55%), and no resting wall motion abnormalities were enrolled. Global myocardial work efficiency (GWE) was assessed using echocardiographic pressure–strain loop analysis. A multivariable-derived nomogram incorporating GWE and clinical biomarkers was developed and externally validated for predicting severe coronary stenosis. Results: The nomogram incorporating GWE, lipoprotein-associated phospholipase A2 (LP-PLA2), N-terminal pro brain natriuretic peptide (NT-proBNP), and serum creatinine (Scr) demonstrated favorable discrimination in both the training set (AUC 0.916, 95% CI 0.866–0.952) and validation set (AUC 0.911, 95% CI 0.853–0.951), with good calibration (mean absolute error: 1.9% vs 3.2% in training vs validation, respectively). Decision curve analysis confirmed clinical utility across all probability thresholds. Conclusions: Our nomogram provides a non-invasive tool for preoperative risk stratification and optimizes the use of invasive diagnostics in stable CAD patients without RWMA.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question. A nomogram combining global myocardial work efficiency and biomarkers predicted severe coronary stenosis with high accuracy in stable CAD patients without RWMA.
Synapse has enriched 10 related papers. Consider them for comparative context: